StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
9
Publishing Date
2023 - 10 - 24
10
2023 - 10 - 04
8
2023 - 05 - 19
9
2023 - 05 - 02
13
2022 - 06 - 13
12
2022 - 05 - 19
9
2022 - 05 - 03
9
2022 - 04 - 25
9
2022 - 03 - 01
11
2022 - 02 - 17
8
2022 - 02 - 15
9
2022 - 01 - 06
8
2022 - 01 - 04
9
2021 - 12 - 20
9
2021 - 12 - 14
8
2021 - 12 - 13
12
2021 - 12 - 09
10
2021 - 12 - 01
8
2021 - 11 - 12
21
2021 - 11 - 11
8
2021 - 11 - 09
12
2021 - 11 - 08
8
2021 - 11 - 04
9
2021 - 11 - 02
10
2021 - 10 - 22
9
2021 - 10 - 21
12
2021 - 10 - 20
12
2021 - 10 - 14
8
2021 - 10 - 12
10
2021 - 10 - 04
13
2021 - 10 - 01
24
2021 - 09 - 15
8
2021 - 09 - 09
8
2021 - 07 - 19
8
2021 - 06 - 23
8
2021 - 06 - 17
8
2021 - 06 - 10
13
2021 - 06 - 07
8
2021 - 06 - 04
11
2021 - 06 - 03
9
2021 - 05 - 12
9
2021 - 05 - 11
8
2021 - 05 - 10
8
2021 - 05 - 04
7
2021 - 04 - 28
8
2021 - 04 - 27
14
2021 - 04 - 26
8
2021 - 04 - 23
7
2021 - 04 - 20
7
2021 - 04 - 19
7
2021 - 04 - 13
9
2021 - 04 - 12
9
2021 - 03 - 29
7
2021 - 03 - 23
7
2021 - 03 - 15
7
2021 - 03 - 08
7
2021 - 01 - 19
13
2021 - 01 - 04
7
2020 - 12 - 21
7
2020 - 12 - 08
8
Sector
Health technology
7
Manufacturing
1
Tags
5g
6
Acquisition
8
Air
7
Alliances
8
Als
29
Annual needham
6
Application
8
Asia
4
Bio-nc
6
Bioscience
12
Biotech
6
Biotech-bay
5
Biotech-beach
13
Biotechnology
5
Cel
14
Clinical-trials-phase-ii
4
Collaboration
7
Conference
101
Corporation
8
Designation
7
Device
4
Disease
4
Distribution
4
Drug
4
Earnings
4
Ema
9
Energy
7
Europe
4
Events
27
Fda
8
Financial results
4
Grant
6
Granted
6
Group
14
Growth
15
Health
58
Intel
5
Iot
12
J.p. morgan healthcare conference
42
Lone-star-bio
5
N/a
264
Offering
5
Patent
5
Pharm-country
7
Pharma
7
Phase 2
6
Phase 3
8
Positive
5
Presentation
5
Research
29
Results
15
Sales
5
System
5
Technology
13
Test
6
Thc
50
Therapeutics
33
Therapy
9
Treatment
10
Trial
15
Entities
Adverum biotechnologies, inc.
1
Biolife solutions, inc.
1
Biomx inc.
1
Cullinan management inc
1
Genprex, inc.
1
Humacyte inc
1
Jaguar health, inc.
1
Nevro corp.
1
Tcr2 therapeutics inc.
1
Symbols
ADVM
1
BLFS
1
CGEM
1
GNPX
1
HUMA
1
JAGX
1
NVRO
1
PHGE
1
TCRR
1
Exchanges
Amex
1
Nasdaq
7
Nyse
1
Crawled Date
2022 - 01 - 05
1
2022 - 01 - 04
8
Crawled Time
01:00
1
12:30
1
15:00
1
15:30
1
16:00
2
20:00
2
23:00
1
Source
www.biospace.com
9
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2022 - 01 - 04
tags :
Therapy
save search
Jaguar Health Launches Canalevia-CA1 (Crofelemer) for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Published:
2022-01-04
(Crawled : 01:00)
- biospace.com/
JAGX
|
$0.1637
-8.19%
-8.92%
130M
|
Health Technology
|
-85.05%
|
O:
3.74%
H:
0.0%
C:
0.0%
treatment
health
diarrhea
therapy
crofelemer
Adverum Biotechnologies Granted Orphan Drug Designation by FDA for Gene Therapy Candidate in Preclinical Development for the Treatment of Blue Cone Monochromacy
Published:
2022-01-04
(Crawled : 23:00)
- biospace.com/
ADVM
|
$11.32
-2.5%
-2.56%
68K
|
Health Technology
|
495.38%
|
O:
-1.54%
H:
1.04%
C:
-5.73%
treatment
fda
gene therapy
drug
granted
preclinical
orphan drug
therapy
biotech
iot
pre-clinical
designation
Humacyte Announces Presentation of First Preclinical Results of the HAV™ in Coronary Artery Bypass Grafting at Advanced Therapies Week Conference
Published:
2022-01-04
(Crawled : 20:00)
- biospace.com/
HUMA
|
$3.13
2.29%
2.24%
1.1M
|
Manufacturing
|
-57.84%
|
O:
2.7%
H:
3.29%
C:
-4.61%
conference
presentation
preclinical
results
therapy
pre-clinical
TCR² Therapeutics and Arbor Biotechnologies Establish Collaboration to Advance Allogeneic TRuC-T Cell Therapies
Published:
2022-01-04
(Crawled : 20:00)
- biospace.com/
TCRR
4
|
$1.48
3.38%
3.9M
|
Health Technology
|
-68.58%
|
O:
-0.42%
H:
0.0%
C:
0.0%
therapeutics
cel
collaboration
biotech
iot
therapy
t-cell
Genprex Expands Gene Therapy Oncology Pipeline to Include Small Cell Lung Cancer
Published:
2022-01-04
(Crawled : 16:00)
- biospace.com/
GNPX
|
$2.26
-1.74%
-1.77%
21K
|
Health Technology
|
44.44%
|
O:
103.92%
H:
0.0%
C:
0.0%
gene therapy
cel
lung cancer
therapy
cancer
BioLife Solutions Collaborates with Seattle Children's to Improve Viral Vector and Cell and Gene Therapy Manufacturing
Published:
2022-01-04
(Crawled : 16:00)
- biospace.com/
BLFS
4
|
$15.12
-5.5%
-5.82%
310K
|
Health Technology
|
-57.09%
|
O:
0.56%
H:
0.0%
C:
-4.75%
gene therapy
cel
therapy
children
collaboration
Nevro Announces UnitedHealthcare Coverage for High-Frequency 10 kHz Therapy for the Treatment of Painful Diabetic Neuropathy
Published:
2022-01-04
(Crawled : 15:30)
- biospace.com/
NVRO
|
News
|
$12.29
-3.23%
0.0%
290K
|
Health Technology
|
-85.59%
|
O:
4.15%
H:
3.5%
C:
0.96%
treatment
health
thc
therapy
diabetic
diabetes
FDA Grants Breakthrough Therapy Designation for Cullinan Oncology’s CLN-081 in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Published:
2022-01-04
(Crawled : 15:00)
- biospace.com/
CGEM
|
$17.84
3.0%
2.91%
1.3M
|
|
5.03%
|
O:
3.27%
H:
8.4%
C:
-1.64%
cln-081
fda
cel
lung cancer
therapy
cancer
breakthrough therapy
designation
CF Foundation Awards Up to $5 Million to BiomX for Potential Phage Therapy
Published:
2022-01-04
(Crawled : 12:30)
- biospace.com/
PHGE
|
$0.2801
-0.07%
0.0%
130K
|
Health Technology
|
-83.13%
|
O:
2.41%
H:
5.29%
C:
-4.12%
awards
potential
therapy
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.